Details
Bretser or Brecer Indications
Multiple myeloma with combined chemotherapy with melphalan and prednisone (first line therapy)
Multiple myeloma in patients who have already received one course of drug treatment or who do not have second-line therapy
Contradictions
Hypersensitivity to bortezomib, boron or any of the auxiliary components of the drug.
Acute diffuse infiltrative pulmonary and pericardial diseases.
Dosage & Administration
Treatment should be initiated under the supervision of a qualified physician with experience in the use of antitumor medicaments.
The solution should be prepared only by qualified medical personnel.